Tumorigenesis and the angiogenic switch

Bergers, Gabriele, Benjamin, Laura E.·2003·Nature reviews. Cancer

Cited by (1,010)

Items 301–400 of 1,010

  1. Expanding roles of ZEB factors in tumorigenesis and tumor progression.
    Ester Sànchez‐Tilló, Laura Siles, Oriol de Barrios, Míriam Cuatrecasas, Eva Cristina Vaquero, Antoni Castells, Antonio A. Postigo · 2011 · Europe PMC (PubMed Central)
  2. Intertwined regulation of angiogenesis and immunity by myeloid cells
    Lee B. Rivera, Gabriele Bergers · 2015 · Trends in Immunology
  3. Tumor cells derived-exosomes as angiogenenic agents: possible therapeutic implications
    Mahdi Ahmadi, Jafar Rezaie · 2020 · Journal of Translational Medicine
  4. Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution
    Fusheng Zhang, Yongsu Ma, Dongqi Li, Jianlei Wei, Kai Chen, Enkui Zhang, Guangnian Liu, Xiangyu Chu, Xinxin Liu, Weikang Liu et al. · 2024 · Journal of Hematology & Oncology
  5. Stress Chaperone GRP78/BiP Confers Chemoresistance to Tumor-Associated Endothelial Cells
    Jenilyn J. Virrey, Dezheng Dong, Caryn Stiles, John B. Patterson, Ligaya Pen, Min Ni, Axel H. Schönthal, Thomas C. Chen, Florence M. Hofman, Amy Shiu Lee · 2008 · Molecular Cancer Research
  6. Hydrogels to model 3D in vitro microenvironment of tumor vascularization
    Song, Hyun-Ho Greco, Park, Kyung Min, Gerecht, Sharon · 2014 · Advanced Drug Delivery Reviews
  7. GBM's multifaceted landscape: highlighting regional and microenvironmental heterogeneity
    Alenoush Vartanian, Sheila Kumari Singh, Sameer Agnihotri, Shila Jalali, Kelly E. Burrell, KD Aldape, Gelareh Mohammed Zadeh · 2014 · Neuro-Oncology
  8. The tumor microenvironment in the post-PAGET era
    Isaac P. Witz, Orlev Levy‐Nissenbaum · 2006 · Cancer Letters
  9. Tumor angiogenesis—characteristics of tumor endothelial cells
    Kyoko Hida, Nako Maishi, Chisaho Torii, Yasuhiro Hida · 2016 · International Journal of Clinical Oncology
  10. Breast Cancer Spheroids Reveal a Differential Cancer Stem Cell Response to Chemotherapeutic Treatment
    Daniel S. Reynolds, Kristie M. Tevis, William A. Blessing, Yolonda Lorig Colson, Muhammad Hamid Zaman, Mark W. Grinstaff · 2017 · Scientific Reports
  11. (Pre-)Clinical Pharmacology and Activity of Pazopanib, a Novel Multikinase Angiogenesis Inhibitor
    Paul Hamberg, Jaap Verweij, Stefan Sleijfer · 2010 · The Oncologist
  12. Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization
    Elisabetta Marcuzzi, Roberta Angioni, Barbara Molon, Bianca Calì · 2018 · International Journal of Molecular Sciences
  13. Glioma-Derived miRNA-Containing Extracellular Vesicles Induce Angiogenesis by Reprogramming Brain Endothelial Cells
    Rocco Lucero, Valentina Zappulli, Alessandro Sammarco, Oscar D. Murillo, Pike-See Cheah, Srimeenakshi Srinivasan, Eric C. Tai, David Tsai Ting, Zhiyun Wei, Matthew E. Roth et al. · 2020 · Cell Reports
  14. FOXO3a Promotes Tumor Cell Invasion through the Induction of Matrix Metalloproteinases
    Peter Störz, Heike R. Döppler, John Alton Copland, Kaylene J. Simpson, Alex Toker · 2009 · Molecular and Cellular Biology
  15. The Microenvironment of Lung Cancer and Therapeutic Implications
    Vivek Mittal, Tina El Rayes, Navneet Narula, Timothy E. McGraw, Nasser Khaled Altorki, Mary Helen Barcellos‐Hoff · 2015 · Advances in experimental medicine and biology
  16. Mechanical Forces in Tumor Angiogenesis
    Matthew R. Zanotelli, Cynthia A. Reinhart‐King · 2018 · Advances in experimental medicine and biology
  17. Suppression of Tumor Growth and Angiogenesis by a Specific Antagonist of the Cell-Surface Expressed Nucleolin
    Damien Destouches, Diala El Khoury, Yamina Hamma‐Kourbali, Bernard Krust, Patricia Albanese, Panagiotis Katsoris, Gilles Guichard, Jean Paul Briand, José Courty, Ara G. Hovanessian · 2008 · PLoS ONE
  18. Magnetic Resonance Perfusion and Permeability Imaging in Brain Tumors
    Saulo Lacerda, Meng Law · 2009 · Neuroimaging Clinics of North America
  19. Integrins in the Spotlight of Cancer
    Daniela Bianconi, Matthias Unseld, Gerald W. Prager · 2016 · International Journal of Molecular Sciences
  20. Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse
    Feng-Ju Huang, Weon‐Kyoo You, Paolo Bonaldo, Thomas N. Seyfried, Elena B. Pasquale, William B. Stallcup · 2010 · Developmental Biology
  21. VEGF-specific Short Hairpin RNA–expressing Oncolytic Adenovirus Elicits Potent Inhibition of Angiogenesis and Tumor Growth
    Ji Young Yoo, Joo-Hang Kim, Young‐Guen Kwon, Eok-Cheon Kim, Nam Kyu Kim, Hye Jin Choi, Chae‐Ok Yun · 2007 · Molecular Therapy
  22. A Critical Role for GRP78/BiP in the Tumor Microenvironment for Neovascularization during Tumor Growth and Metastasis
    Dezheng Dong, Christopher J. Stapleton, Biquan Luo, Shigang Xiong, Wei Ye, Yi Zhang, Niyati Jhaveri, Genyuan Zhu, Risheng Ye, Zhi Liu et al. · 2011 · Cancer Research
  23. Antitumor and anti-angiogenesis effects of thymoquinone on osteosarcoma through the NF-κB pathway
    Lei Peng, An Liu, Yue Liang Shen, Huazi Xu, Shizhou Yang, Xiaozhou Ying, WEI LIAO, Hai-xiao Liu, Zhong-Qin Lin, Qingyu Chen et al. · 2012 · Oncology Reports
  24. Vascular endothelial growth factor induces proliferation of breast cancer cells and inhibits the anti-proliferative activity of anti-hormones
    Yayun Liang, Rolf A. Brekken, Salman M. Hyder · 2006 · Endocrine Related Cancer
  25. Metronomic Chemotherapy Enhances the Efficacy of Antivascular Therapy in Ovarian Cancer
    Aparna A. Kamat, Tae Jin Kim, Charles N. Landen, Chunhua Lu, Liz Y. Han, Yvonne Gail Lin, William M. Merritt, Premal H. Thaker, David Marc Gershenson, Farideh Z. Bischoff et al. · 2007 · Cancer Research
  26. Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression
    Shaji Kunnathu Kumar, Thomas Elmer Witzig, Michael Timm, Jessica L. Haug, Linda E. Wellik, Teresa K. Kimlinger, Philip R. Greipp, S. Vincent Rajkumar · 2004 · Blood
  27. Phenethyl Isothiocyanate Inhibits Angiogenesis In vitro and Ex vivo
    Dong Xiao, Shivendra Vikram Singh · 2007 · Cancer Research
  28. The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited
    Dzobo, Kevin, Senthebane, Dimakatso A., Dandara, Collet · 2023 · Cancers
  29. Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis
    Beatrice Grabner, Daniel Schramek, Kristina M. Mueller, Herwig Peter Moll, Jasmin Svinka, Thomas Hoffmann, Eva Bauer, Leander Blaas, Natascha Hruschka, Katalin Zboray et al. · 2015 · Nature Communications
  30. Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT
    Yang Zhou, Sudipta Chakraborty, Shuang Liu · 2011 · Theranostics
  31. Glioblastoma: Therapeutic challenges, what lies ahead
    Flávia Regina Souza Lima, Suzana Assad Kahn, Rossana Colla Soletti, Deborah Biasoli, Tercia Rodrigues Alves, Anna Carolina Carvalho da Fonseca, Celina Garcia, Luciana Ferreira Romão, José M. Brito, Rosenilde Carvalho de Holanda Afonso et al. · 2012 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  32. Endothelial cells in tumor microenvironment: insights and perspectives
    Patrizia Leone, Eleonora Malerba, Nicola Susca, Elvira Favoino, Federico Perosa, Giuliano Brunori, Marcella Prete, Vito Racanelli · 2024 · Frontiers in Immunology
  33. Tumor endothelial markers: new targets for cancer therapy
    Akash Nanda, Brad St. Croix · 2003 · Current Opinion in Oncology
  34. Platelet-derived growth factor receptor (PDGFR): A target for anticancer therapeutics
    R BOARD, Gordon C. Jayson · 2005 · Drug Resistance Updates
  35. Targeting FGFR/PDGFR/VEGFR Impairs Tumor Growth, Angiogenesis, and Metastasis by Effects on Tumor Cells, Endothelial Cells, and Pericytes in Pancreatic Cancer
    Johannes Taeger, Christian Moser, Claus Hellerbrand, Maria Elzbieta Mycielska, Gabriel Glockzin, Hans Jürgen Schlitt, Edward Kenneth Geissler, Oliver Stoeltzing, Sven Arke Lang · 2011 · Molecular Cancer Therapeutics
  36. New insights into the correlations between circulating tumor cells and target organ metastasis
    Qinru Zhan, Bixia Liu, Xiaohua Situ, Yuting Luo, Tongze Fu, Yanxia Wang, Zhongpeng Xie, Lijuan Ren, Ying Jie Zhu, Weiling He et al. · 2023 · Signal Transduction and Targeted Therapy
  37. Paths of FGFR-driven tumorigenesis
    Victor D. Acevedo, Michael Ittmann, David M. Spencer · 2009 · Cell Cycle
  38. Essential Role of Vav Family Guanine Nucleotide Exchange Factors in EphA Receptor-Mediated Angiogenesis
    Sonja Hunter, Guanglei Zhuang, Dana M. Brantley‐Sieders, Wojciech Swat, Christopher W. Cowan, Jin Chen · 2006 · Molecular and Cellular Biology
  39. Tumor Neovascularization and Developments in Therapeutics
    Yuki Katayama, Junji Uchino, Yusuke Chihara, Nobuyo Tamiya, Yoshiko Kaneko, Tadaaki Yamada, Koichi Takayama · 2019 · Cancers
  40. New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy
    Qiujun Guo, Zhichao Jin, Yuan Yuan, Rui Liu, Tao Xu, Huamin Wei, Xinyao Xu, Shulin He, Shuntai Chen, Zhan Shi et al. · 2016 · Journal of Immunology Research
  41. Interleukin-6: An angiogenic target in solid tumours
    Kathryn Middleton, Joanna E. Jones, Zarnie Lwin, Jermaine Ian George Coward · 2013 · Critical Reviews in Oncology/Hematology
  42. The role of the organ microenvironment in the biology and therapy of cancer metastasis
    Isaiah J. Fidler, Sun‐Jin Kim, Robert R. Langley · 2006 · Journal of Cellular Biochemistry
  43. E-3810 Is a Potent Dual Inhibitor of VEGFR and FGFR that Exerts Antitumor Activity in Multiple Preclinical Models
    Ezia Bello, Gennaro Colella, Valentina Scarlato, Paolo Oliva, Alexander Berndt, Giovanni Valbusa, Sonia Colombo Serra, Maurizio D’Incalci, Ennio Cavalletti, Raffaella Giavazzi et al. · 2011 · Cancer Research
  44. Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells
    Neil T. Pfister, Vitalay Fomin, Kausik Regunath, Jeffrey Y. Zhou, Wen Zhou, Laxmi Silwal‐Pandit, William A. Freed-Pastor, Oleg Laptenko, Suat Peng Neo, Jill Bargonetti et al. · 2015 · Genes & Development
  45. Guidelines for the selection of functional assays to evaluate the hallmarks of cancer
    Otília Menyhárt, Hajnalka Papp, Saraswati V. Sukumar, Reinhold Schäfer, Luca Magnani, Oriol de Barrios, Balázs Győrffy · 2016 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  46. Mechanisms of Disease: angiogenesis and the management of breast cancer
    Susana N. Banerjee, Mitch Dowsett, Alan Ashworth, Lesley‐Ann Martin · 2007 · Nature Clinical Practice Oncology
  47. HIF2α cooperates with RAS to promote lung tumorigenesis in mice
    Kim, William Y., Perera, Samanthi, Zhou, Bing, Carretero, Julian, Yeh, Jen Jen, Heathcote, Samuel A., Jackson, Autumn L., Nikolinakos, Petros, Ospina, Beatriz, Naumov, George et al. · 2009 · Journal of Clinical Investigation
  48. Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme
    Yasushi Soda, Chad Myskiw, Amy Rommel, Inder M. Verma · 2013 · Journal of Molecular Medicine
  49. Gold nanoparticles and angiogenesis: molecular mechanisms and biomedical applications
    Ruba S. Darweesh, Nehad M. Ayoub, Sami Nazzal · 2019 · International Journal of Nanomedicine
  50. Tunneling Nanotubes and Tumor Microtubes in Cancer
    Cora Roehlecke, Mirko H. H. Schmidt · 2020 · Cancers
  51. MT1-MMP: Universal or particular player in angiogenesis?
    Laura Genı́s, Beatriz G. Gálvez, Pilar Gonzalo, Alicia G. Arroyo · 2006 · Cancer and Metastasis Reviews
  52. Molecular Connections between Cancer Cell Metabolism and the Tumor Microenvironment
    Calvin Justus, Edward J. Sanderlin, Li V. Yang · 2015 · International Journal of Molecular Sciences
  53. Combined fluorescence and reflectance spectroscopy for in vivo quantification of cancer biomarkers in low- and high-grade glioma surgery
    Pablo Andres Valdes, Frédéric Leblond, Keith D. Paulsen, Anthony Kim, Brian C. Wilson, Olga M. Conde, Brent T. Harris, David W. Roberts · 2011 · Journal of Biomedical Optics
  54. Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer
    Qiang Lan, Sanam Peyvandi, Nathalie Duffey, Yu-Ting Huang, David Barras, Werner Held, François Richard, Mauro Delorenzi, Christos P. Sotiriou, Christine Desmedt et al. · 2018 · Oncogene
  55. Connective tissue growth factor (CTGF) and cancer progression
    Chia‐Yu Chu, Cheng-Chi Chang, Ekambaranellore Prakash, Min‐Liang Kuo · 2008 · Journal of Biomedical Science
  56. Development of Second-Generation VEGFR Tyrosine Kinase Inhibitors: Current Status
    Pankaj Bhargava, Murray O. Robinson · 2011 · Current Oncology Reports
  57. Vascular Mimicry: A Novel Neovascularization Mechanism Driving Anti-Angiogenic Therapy (AAT) Resistance in Glioblastoma
    Kartik Angara, Thaiz F. Borin, Ali S. Arbab · 2017 · Translational Oncology
  58. Enzymatic esterification of flavonoids with unsaturated fatty acids: Effect of the novel esters on vascular endothelial growth factor release from K562 cells
    Fotini Mellou, Heleni V. Loutrari, Haralambos Stamatis, Charis Roussos, Fragiskos N. Kolisis · 2006 · Process Biochemistry
  59. Vascular Damaging Agents
    Daniel M. Patterson, Gordon J.S. Rustin · 2007 · Clinical Oncology
  60. Mechanisms of action of novel agents for prostate cancer chemoprevention
    Rana Pratap Singh, Rajesh Agarwal · 2006 · Endocrine Related Cancer
  61. PI-88 and Novel Heparan Sulfate Mimetics Inhibit Angiogenesis
    Vito Ferro, Keith S. Dredge, Ligong Liu, Edward Hammond, Ian Bytheway, Caiping Li, Ken D. Johnstone, Tomislav Karoli, Kat Davis, Elizabeth Copeman et al. · 2007 · Seminars in Thrombosis and Hemostasis
  62. Standards of care and novel approaches in the management of glioblastoma multiforme
    Andreas Felix Hottinger, Roger Stupp, Krisztián Homicskó · 2014 · 癌症:英文版
  63. Advances in the structural biology, design and clinical development of VEGF-R kinase inhibitors for the treatment of angiogenesis
    Paul William Manley, Guido Bold, Josef Brüggen, Gabrielle Fendrich, Pascal Furet, Jürgen Mestan, Christian Schnell, Barbara Stolz, Thomas Meyer, Bernd Meyhack et al. · 2003 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  64. Targeting activin receptor-like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapies
    Hu-Lowe, Dana D., Chen, Enhong, Zhang, Lianglin, Watson, Katherine D., Mancuso, Patrizia, Lappin, Patrick, Wickman, Grant, Chen, Jeffrey H., Wang, Jianying, Jiang, Xin et al. · 2011 · Cancer Research
  65. VEGF121-Conjugated Mesoporous Silica Nanoparticle: A Tumor Targeted Drug Delivery System
    Shreya Goel, Feng Chen, Hao Hong, Hector F. Valdovinos, Reinier Hernandez, Sixiang Shi, Todd E. Barnhart, Weibo Cai · 2014 · ACS Applied Materials & Interfaces
  66. Tumor Dormancy and Cancer Stem Cells: Two Sides of the Same Coin?
    Sonja Kleffel, Tobias Schatton · 2012 · Advances in experimental medicine and biology
  67. Therapeutic angiogenesis for myocardial ischemia revisited: basic biological concepts and focus on latest clinical trials
    Sofoclis Mitsos, Konstantinos H. Katsanos, Efstratios N. Koletsis, George C. Kagadis, Nikolaos Anastasiou, Αθανάσιος Διαμαντόπουλος, Dimitrios Karnabatidis, Dimitris Dougenis · 2011 · Angiogenesis
  68. Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer
    Georg Lurje, W. Zhang, Anne Maria Schultheis, Dongyun Yang, Susan G. Groshen, Andrew Eugene Hendifar, Hatim Husain, Michael A. Gordon, Fumio Nagashima, Heung-Moon Chang et al. · 2008 · Annals of Oncology
  69. Transformed Drosophila Cells Evade Diet-Mediated Insulin Resistance through Wingless Signaling
    Susumu Hirabayashi, Thomas Baranski, Ross Leigh Cagan · 2013 · Cell
  70. Biocompatible and biodegradable nanoparticles for enhancement of anti-cancer activities of phytochemicals
    Chuan Li, Jia Zhang, Yu-Jiao ZU, Shu-Fang NIE, Jun Cao, Qian WANG, Shaoping Nie, Zeyuan Deng, Mingyong Xie, Shu Fen Wang · 2015 · Chinese Journal of Natural Medicines
  71. Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy
    Ismael Riquelme, Kathleen Saavedra, Jaime A. Espinoza, Helga L. Weber, Patricia García, Bruno Nervi, Marcelo Garrido S, Alejandro H. Corvalán, Juan Carlos Roa, Carolina Bizama · 2015 · Oncotarget
  72. Targeting the Tumor Microenvironment: Focus on Angiogenesis
    Fengjuan Fan, Alexander Schimming, Dirk Jaeger, Klaus Podar · 2011 · Journal of Oncology
  73. Angiogenesis-Related Pathways in the Pathogenesis of Ovarian Cancer
    Nikos G. Gavalas, Michalis Liontos, Sofia Paraskevi Trachana, Tina Bagratuni, Calliope Arapinis, Christine‐Ivy Liacos, Meletios Athanasios Dimopoulos, Aristotle Bamias · 2013 · International Journal of Molecular Sciences
  74. Advancements in combining targeted therapy and immunotherapy for colorectal cancer
    Manisha Singh, Van Karlyle Morris, Irfan N. Bandey, David S. Hong, Scott Kopetz · 2024 · Trends in cancer
  75. Physiological and tumor-associated angiogenesis: Key factors and therapy targeting VEGF/VEGFR pathway
    Patryk Lorenc, Agata Sikorska, Sara Molenda, Natalia Guzniczak, Hanna Dams‐Kozlowska, Anna Florczak · 2024 · Biomedicine & Pharmacotherapy
  76. Tumor Angiogenic Marker Expression Levels during Tumor Growth: Longitudinal Assessment with Molecularly Targeted Microbubbles and US Imaging
    Nirupama Deshpande, Ying Ren, Kira Foygel, Jarrett Rosenberg, Jürgen K. Willmann · 2011 · Radiology
  77. The Role of Tissue Inhibitors of Metalloproteinases in Tumorigenesis and Metastasis
    William Cruz‐Muñoz, Rama Khokha · 2008 · Critical Reviews in Clinical Laboratory Sciences
  78. 3D culture broadly regulates tumor cell hypoxia response and angiogenesis via pro-inflammatory pathways
    Peter F. DelNero, Maureen E. Lane, Scott S. Verbridge, Brian J. Kwee, Pouneh Kermani, Barbara L. Hempstead, Abraham Duncan Stroock, Claudia Fischbach · 2015 · Biomaterials
  79. Towards novel paradigms for cancer therapy
    Valeria Pavet, Maximiliano M. Portal, Jean-Francois Moulin, Raoul Herbrecht, Hinrich Gronemeyer · 2010 · Oncogene
  80. A microfluidic platform for quantitative analysis of cancer angiogenesis and intravasation
    Lee, Hyunjae, Park, Woohyun, Ryu, Hyunryul, Jeon, Noo Li · 2014 · Biomicrofluidics
  81. Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A
    Hongxia Chen, Lingmin Li, Shaojun Wang, Yupeng Lei, Qi Ge, Nonghua Lv, Xiaodong Zhou, Changyan Chen · 2014 · Oncotarget
  82. SGLT-2 Inhibitors in Cancer Treatment—Mechanisms of Action and Emerging New Perspectives
    Mieczysław Dutka, Rafał Bobiński, Tomasz Francuz, Wojciech Garczorz, Karolina Zimmer, Tomasz Piotr Ilczak, Michał Ćwiertnia, Maciej Błażej Hajduga · 2022 · Cancers
  83. Angiogenesis in cancer: molecular mechanisms, clinical impact
    Martin Eichhorn, Axel Kleespies, Martin Kurt Angele, K.‐W. Jauch, Christiane J. Bruns · 2007 · Langenbeck s Archives of Surgery
  84. The bone marrow constitutes a reservoir of pericyte progenitors
    Chrystelle Lamagna, Gabriele Bergers · 2006 · Journal of Leukocyte Biology
  85. Central role of lactic acidosis in cancer cell resistance to glucose deprivation‐induced cell death
    Hao Wu, Zonghui Ding, Danqing Hu, Feifei Sun, Chunyan Dai, Jiansheng Xie, Xun Hu · 2011 · The Journal of Pathology
  86. Back to basics: how natural products can provide the basis for new therapeutics
    Amit Deorukhkar, Sunil Krishnan, Gautam Sethi, Bharat Bhushan Aggarwal · 2007 · Expert Opinion on Investigational Drugs
  87. Bone Formation and Neovascularization Mediated by Mesenchymal Stem Cells and Endothelial Cells in Critical-Sized Calvarial Defects
    Sebastian Koob, Nestor Torio‐Padron, G. Björn Stark, Christian Hannig, Zoran B. Stanković, Günter Finkenzeller · 2010 · Tissue Engineering Part A
  88. Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor Promote Malignant Growth of Cells from Head and Neck Squamous Cell Carcinomas In vivo
    Claudia M. Gutschalk, Christel C. Herold‐Mende, Norbert E. Fusenig, Margareta M. Mueller · 2006 · Cancer Research
  89. Cyclooxygenase-2 Inhibitors Decrease Vascular Endothelial Growth Factor Expression in Colon Cancer Cells by Enhanced Degradation of Sp1 and Sp4 Proteins
    Maen Abdelrahim, Stephen H Safe · 2005 · Molecular Pharmacology
  90. Cellular Interactions in the Tumor Microenvironment: The Role of Secretome
    Bianca Rodrigues da Cunha, Célia Domingos, Ana Carolina Buzzo Stefanini, Tiago Henrique, Giovana Mussi Polachini, Pedro Castelo‐Branco, Eloíza H. Tajara · 2019 · Journal of Cancer
  91. Tlx acts as a proangiogenic switch by regulating extracellular assembly of fibronectin matrices in retinal astrocytes
    Akiyoshi Uemura · 2006 · Journal of Clinical Investigation
  92. What is pH regulation, and why do cancer cells need it?
    Pawel Swietach · 2019 · Cancer and Metastasis Reviews
  93. Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins
    Luca Anfosso, Thomas Efferth, Adriana Albini, Ulrich Pfeffer · 2006 · The Pharmacogenomics Journal
  94. Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF
    Markus Otto Guba, Maksim Yezhelyev, Martin Eichhorn, Gerald Schmid, Ivan Ischenko, Armine Papyan, Christian Graeb, Hendrik Seeliger, Edward Kenneth Geissler, Karl‐Walter Jauch et al. · 2005 · Blood
  95. Glioblastoma cells: A heterogeneous and fatal tumor interacting with the parenchyma
    Tercia Rodrigues Alves, Flávia Regina Souza Lima, Suzana Assad Kahn, Denise S. Lobo, Luiz Gustavo Dubois, Rossana Colla Soletti, Helena L. Borges, Vivaldo Moura‐Neto · 2011 · Life Sciences
  96. Volatile anaesthetics enhance the metastasis related cellular signalling including CXCR2 of ovarian cancer cells
    Masae Iwasaki, Hailin Zhao, Tanweer Jaffer, Sandeep Unwith, Laura L. Benzonana, Qingquan Lian, Atsuhiro Sakamoto, Daqing Ma · 2016 · Oncotarget
  97. The mechanism of tumour cell death by metal-based anticancer drugs is not only a matter of DNA interactions
    Alberta Bergamo, Paul J. Dyson, Gianni Sava · 2018 · Coordination Chemistry Reviews
  98. Vascular Proliferation Is Important for Clinical Progress of Endometrial Cancer
    Ingunn M. Stefansson, Helga Birgitte Salvesen, Lars A. Akslen · 2006 · Cancer Research
  99. Characterization of a von Hippel Lindau Pathway Involved in Extracellular Matrix Remodeling, Cell Invasion, and Angiogenesis
    Ghada Kurban, Valérie Hudon, Eric Duplan, Michael Ohh, Arnim Pause · 2006 · Cancer Research
  100. Outgrowth of human liver metastases after resection of the primary colorectal tumor: A shift in the balance between apoptosis and proliferation
    Charlotte F.J.M. Peeters, Robert M.W. de Waal, Theo Wobbes, Johan R. Westphal, Theo J. M. Ruers · 2006 · International Journal of Cancer